Science ❯Biology ❯Immunology

Cancer Immunotherapy

T Cell Activation Chimeric Antigen Receptor T-cells T Cell Receptor Therapy Monoclonal Antibodies TIL Therapy

Engineered CAR-T Cells Target PD-L1 to Deliver IL-12 at Tumors, Showing Solid-Tumor Gains in Mice

The strategy tethers IL-12 to a PD-L1 blocker to concentrate immune activation at the tumor with minimal systemic toxicity.

AI Drives Next-Generation Melanoma Immunotherapies Toward In Vivo Testing

Nagoya University Advances Eva1-Targeted CAR-T Therapy to Preclinical Safety Testing